Phase 1 Study of Levocetirizine

NCT02447393 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis

Interventions

DRUG: levocetirizine
DRUG: cetirizine
DRUG: placebo

Sponsor

GlaxoSmithKline